What is the evidence for the use of probiotics in functional disorders? (Q37216850)

19 August 2017

1 reference

title

What is the evidence for the use of probiotics in functional disorders? (English)

1 reference

19 August 2017

0 references

Eamonn M M Quigley

1

1 reference

19 August 2017

1 August 2008

1 reference

Current gastroenterology reports

19 August 2017

1 reference

19 August 2017

10

1 reference

19 August 2017

379-384

1 reference

19 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-008-0072-1

19 August 2017

0 references

cites work

Use of probiotics for prevention of radiation-induced diarrhea

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-008-0072-1

Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-008-0072-1

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

21 January 2018

1 reference

12 December 2020

Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.

1 reference

12 December 2020

Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics

1 reference

12 December 2020

Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

1 reference

12 December 2020

Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children

1 reference

12 December 2020

Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management

1 reference

12 December 2020

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

1 reference

12 December 2020

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

1 reference

12 December 2020

Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen.

1 reference

12 December 2020

Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.

1 reference

12 December 2020

Gut microbiota: mining for therapeutic potential

1 reference

12 December 2020

Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology

1 reference

12 December 2020

Role for protease activity in visceral pain in irritable bowel syndrome

1 reference

12 December 2020

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

1 reference

12 December 2020

Activation of the mucosal immune system in irritable bowel syndrome

1 reference

12 December 2020

Irritable Bowel Syndrome: Shifting the Focus Toward the Gut Microbiota

1 reference

12 December 2020

Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome

1 reference

12 December 2020

Germs, gas and the gut; the evolving role of the enteric flora in IBS.

1 reference

12 December 2020

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

1 reference

12 December 2020

Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits

1 reference

12 December 2020

Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation

1 reference

12 December 2020

Probiotics: a perspective on problems and pitfalls

1 reference

12 December 2020

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

1 reference

12 December 2020

Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

Immune activation in patients with irritable bowel syndrome

1 reference

12 December 2020

Clinical efficacy of probiotics: review of the evidence with focus on children

1 reference

12 December 2020

Effectiveness of probiotics in the treatment of irritable bowel syndrome

1 reference

12 December 2020

The role of psychological and biological factors in postinfective gut dysfunction

1 reference

12 December 2020

Efficacy of probiotics and nutrients in functional gastrointestinal disorders: a preliminary clinical trial

1 reference

12 December 2020

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

1 reference

12 December 2020

Gut flora in health and disease

1 reference

12 December 2020

The host-microbe interface within the gut

1 reference

12 December 2020

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

1 reference

12 December 2020

Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial

1 reference

12 December 2020

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

1 reference

12 December 2020

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota

1 reference

12 December 2020

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

1 reference

12 December 2020

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

1 reference

12 December 2020

Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight)

1 reference

12 December 2020

Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation

1 reference

12 December 2020

Microbial-gut interactions in health and disease. Probiotics.

1 reference

12 December 2020

Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls

1 reference

12 December 2020

Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled, 1-year extension of a previously published controlled clinical trial

1 reference

12 December 2020

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

1 reference

12 December 2020

Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication

1 reference

12 December 2020

Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity

1 reference

12 December 2020

Meta-analysis of probiotics for the prevention of traveler's diarrhea

1 reference

12 December 2020

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

1 reference

12 December 2020

A 51-year-old with irritable bowel syndrome: test or treat for bacterial overgrowth?

1 reference

12 December 2020

Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials

1 reference

12 December 2020

Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly

1 reference

12 December 2020

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

1 reference

12 December 2020

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

1 reference

12 December 2020

Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome

1 reference

12 December 2020

Antibiotic associated diarrhoea: a controlled study comparing plain antibiotic with those containing protected lactobacilli.

1 reference

12 December 2020

The D-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model

1 reference

12 December 2020

Probiotics for treating infectious diarrhoea

1 reference

12 December 2020

Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea

1 reference

12 December 2020

Bacteriotherapy using fecal flora: toying with human motions

1 reference

12 December 2020

Probiotics and prebiotics: effects on diarrhea

1 reference

12 December 2020

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

1 reference

12 December 2020

10.1007/S11894-008-0072-1

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18627649